A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)

NCT04005586 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Aphakia
Cataract

Interventions

DEVICE: Light Delivery Device (LDD)

Sponsor

RxSight, Inc.